{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:16:51Z","timestamp":1789834611996,"version":"4.0.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01810"],"award-info":[{"award-number":["PI15\/01810"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI17\/00083"],"award-info":[{"award-number":["PI17\/00083"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s10067-020-04961-4","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T22:59:35Z","timestamp":1580252375000},"page":"1871-1880","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["HDL cholesterol efflux capacity is related to disease activity in psoriatic arthritis patients"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5267","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Vanesa","family":"Hern\u00e1ndez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefan\u00eda","family":"Armas-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiurma","family":"S\u00e1nchez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 David","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4139-9295","authenticated-orcid":false,"given":"Federico","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"4961_CR1","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/ard.2008.094839","volume":"68","author":"DD Gladman","year":"2009","unstructured":"Gladman DD, Ang M, Su L, Tom BD, Schentag CT, Farewell VT (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68:1131\u20131135","journal-title":"Ann Rheum Dis"},{"key":"4961_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1136\/annrheumdis-2011-201194","volume":"72","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72:211\u2013216","journal-title":"Ann Rheum Dis"},{"key":"4961_CR3","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1136\/annrheumdis-2015-207980","volume":"75","author":"L Eder","year":"2016","unstructured":"Eder L, Wu Y, Chandran V, Cook R, Gladman DD (2016) Incidence and predictors for cardiovascular events in patients with psoriatic arthritis. Ann Rheum Dis 75:1680\u20131686","journal-title":"Ann Rheum Dis"},{"key":"4961_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3899\/jrheum.150757","volume":"43","author":"M Haroon","year":"2016","unstructured":"Haroon M, Rafiq Chaudhry AB, Fitzgerald O (2016) Higher prevalence of metabolic syndrome in patients with psoriatic arthritis: a comparison with a control group of noninflammatory rheumatologic conditions. J Rheumatol 43:463\u2013464","journal-title":"J Rheumatol"},{"key":"4961_CR5","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.3899\/jrheum.090822","volume":"37","author":"AM Tobin","year":"2010","unstructured":"Tobin AM, Veale DJ, Fitzgerald O, Rogers S, Collins P, O\u2019Shea D, Kirby B (2010) Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis. J Rheumatol 37:1386\u20131394","journal-title":"J Rheumatol"},{"key":"4961_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/ard.59.11.904","volume":"59","author":"SM Jones","year":"2000","unstructured":"Jones SM, Harris CP, Lloyd J, Stirling CA, Reckless JP, McHugh NJ (2000) Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann Rheum Dis 59:904\u2013909","journal-title":"Ann Rheum Dis"},{"key":"4961_CR7","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/rheumatology\/ken090","volume":"47","author":"LS Tam","year":"2008","unstructured":"Tam LS, Tomlinson B, Chu TT, Li M, Leung YY, Kwok LW, Li TK, Yu T, Zhu YE, Wong KC, Kun EW, Li EK (2008) Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation. Rheumatology (Oxford) 47:718\u2013723","journal-title":"Rheumatology (Oxford)"},{"key":"4961_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/0049-0172(92)90017-8","volume":"22","author":"MB Lazarevic","year":"1992","unstructured":"Lazarevic MB, Vitic J, Mladenovic V, Myones BL, Skosey JL, Swedler WI (1992) Dyslipoproteinemia in the course of active rheumatoid arthritis. Semin Arthritis Rheum 22:172\u2013178","journal-title":"Semin Arthritis Rheum"},{"key":"4961_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1046\/j.1468-3083.2003.00792_11.x","volume":"17","author":"AH Skoczynska","year":"2003","unstructured":"Skoczynska AH, Turczyn B, Barancewicz-Losek M, Martynowicz H (2003) High-density lipoprotein cholesterol in patients with psoriatic arthritis. J Eur Acad Dermatol Venereol 17:362\u2013363","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"4961_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"MJ Peters","year":"2004","unstructured":"Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585\u2013592","journal-title":"Semin Arthritis Rheum"},{"key":"4961_CR11","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","volume":"113","author":"M Cuchel","year":"2006","unstructured":"Cuchel M, Rader DJ (2006) Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? Circulation 113:2548\u20132555","journal-title":"Circulation"},{"key":"4961_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/j.1365-2796.2007.01898.x","volume":"263","author":"AR Tall","year":"2008","unstructured":"Tall AR (2008) Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 263:256\u2013273","journal-title":"J Intern Med"},{"key":"4961_CR13","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1056\/NEJMoa1001689","volume":"364","author":"AV Khera","year":"2011","unstructured":"Khera AV, Cuchel M, de la Llera-Moya M, Rodrigues A, Burke MF, Jafri K, French BC, Phillips JA, Mucksavage ML, Wilensky RL, Mohler ER, Rothblat GH, Rader DJ (2011) Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 364:127\u2013135","journal-title":"N Engl J Med"},{"key":"4961_CR14","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","volume":"371","author":"A Rohatgi","year":"2014","unstructured":"Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW (2014) HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 371:2383\u20132393","journal-title":"N Engl J Med"},{"key":"4961_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13075-017-1311-3","volume":"19","author":"B Tejera-Segura","year":"2017","unstructured":"Tejera-Segura B, Macia-Diaz M, Machado JD, de Vera-Gonzalez A, Garcia-Dopico JA, Olmos JM, Hernandez JL, Diaz-Gonzalez F, Gonzalez-Gay MA, Ferraz-Amaro I (2017) HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis. Arthritis Res Ther 19:113","journal-title":"Arthritis Res Ther"},{"key":"4961_CR16","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, Group CS (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665\u20132673","journal-title":"Arthritis Rheum"},{"key":"4961_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2015-207507","volume":"75","author":"MM Schoels","year":"2016","unstructured":"Schoels MM, Aletaha D, Alasti F, Smolen JS (2016) Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score. Ann Rheum Dis 75:811\u2013818","journal-title":"Ann Rheum Dis"},{"key":"4961_CR18","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hoff MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44\u201348","journal-title":"Arthritis Rheum"},{"key":"4961_CR19","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1002\/1529-0131(199910)42:10<2220::AID-ANR26>3.0.CO;2-5","volume":"42","author":"T Pincus","year":"1999","unstructured":"Pincus T, Swearingen C, Wolfe F (1999) Toward a multidimensional health assessment questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum 42:2220\u20132230","journal-title":"Arthritis Rheum"},{"key":"4961_CR20","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3899\/jrheum.180881","volume":"46","author":"JC Quevedo-Abeledo","year":"2019","unstructured":"Quevedo-Abeledo JC, Rua-Figueroa I, Sanchez-Perez H, Tejera-Segura B, de Vera-Gonzalez A, Gonzalez-Delgado A, Llorca J, Gonzalez-Gay MA, Ferraz-Amaro I (2019) Disease damage influences cardiovascular risk reclassification based on carotid ultrasound in patients with systemic lupus erythematosus. J Rheumatol 46:483\u2013491","journal-title":"J Rheumatol"},{"key":"4961_CR21","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1136\/annrheumdis-2013-204933","volume":"73","author":"MA Gonzalez-Gay","year":"2014","unstructured":"Gonzalez-Gay MA, Gonzalez-Juanatey C (2014) Inflammation and lipid profile in rheumatoid arthritis: bridging an apparent paradox. Ann Rheum Dis 73:1281\u20131283","journal-title":"Ann Rheum Dis"},{"key":"4961_CR22","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1136\/ard.2010.135871","volume":"70","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, Gabriel SE (2011) Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis 70:482\u2013487","journal-title":"Ann Rheum Dis"},{"key":"4961_CR23","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrrheum.2013.91","volume":"9","author":"J Robertson","year":"2013","unstructured":"Robertson J, Peters MJ, McInnes IB, Sattar N (2013) Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm. Nat Rev Rheumatol 9:513\u2013523","journal-title":"Nat Rev Rheumatol"},{"key":"4961_CR24","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1136\/annrheumdis-2011-200493","volume":"71","author":"C Charles-Schoeman","year":"2012","unstructured":"Charles-Schoeman C, Lee YY, Grijalva V, Amjadi S, FitzGerald J, Ranganath VK, Taylor M, McMahon M, Paulus HE, Reddy ST (2012) Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis 71:1157\u20131162","journal-title":"Ann Rheum Dis"},{"key":"4961_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","volume":"73","author":"N Ronda","year":"2014","unstructured":"Ronda N, Favari E, Borghi MO, Ingegnoli F, Gerosa M, Chighizola C, Zimetti F, Adorni MP, Bernini F, Meroni PL (2014) Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 73:609\u2013615","journal-title":"Ann Rheum Dis"},{"key":"4961_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1055\/a-0833-4627","volume":"51","author":"I Ferraz-Amaro","year":"2019","unstructured":"Ferraz-Amaro I, Hernandez-Hernandez MV, Tejera-Segura B, Delgado-Frias E, Macia-Diaz M, Machado JD, Diaz-Gonzalez F (2019) Effect of IL-6 receptor blockade on proprotein convertase subtilisin\/kexin type-9 and cholesterol efflux capacity in rheumatoid arthritis patients. Horm Metab Res 51:200\u2013209","journal-title":"Horm Metab Res"},{"key":"4961_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4081\/reumatismo.2018.1061","volume":"70","author":"M Bellan","year":"2018","unstructured":"Bellan M, Bor S, Gibbin A, Gualerzi A, Favretto S, Guaschino G, Bonometti R, Rossini A, Sola D, Pedrazzoli R, Carnevale Schianca GP, Pirisi M, Sainaghi PP (2018) Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis. Reumatismo 70:232\u2013240","journal-title":"Reumatismo"},{"key":"4961_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/annrheumdis-2017-211998","volume":"77","author":"LJJ van Mens","year":"2018","unstructured":"van Mens LJJ, van de Sande MGH, van Kuijk AWR, Baeten D, Coates LC (2018) Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort. Ann Rheum Dis 77:251\u2013257","journal-title":"Ann Rheum Dis"},{"key":"4961_CR29","doi-asserted-by":"publisher","first-page":"528105","DOI":"10.1155\/2014\/528105","volume":"2014","author":"F Salaffi","year":"2014","unstructured":"Salaffi F, Ciapetti A, Carotti M, Gasparini S, Gutierrez M (2014) Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world. Biomed Res Int 2014:528105","journal-title":"Biomed Res Int"},{"key":"4961_CR30","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1136\/annrheumdis-2016-210390","volume":"76","author":"J Shen","year":"2017","unstructured":"Shen J, Wong KT, Cheng IT, Shang Q, Li EK, Wong P, Kun EW, Law MY, Yip R, Yim I, Ying S, Li M, Li TK, Wong CK, Zhu TY, Lee JJ, Chang M, Lee AP, Tam LS (2017) Increased prevalence of coronary plaque in patients with psoriatic arthritis without prior diagnosis of coronary artery disease. Ann Rheum Dis 76:1237\u20131244","journal-title":"Ann Rheum Dis"},{"key":"4961_CR31","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/art.40389","volume":"70","author":"A Szentpetery","year":"2018","unstructured":"Szentpetery A, Healy GM, Brady D, Haroon M, Gallagher P, Redmond CE, Fleming H, Duignan J, Dodd JD, FitzGerald O (2018) Higher coronary plaque burden in psoriatic arthritis is independent of metabolic syndrome and associated with underlying disease severity. Arthritis Rheum 70:396\u2013407","journal-title":"Arthritis Rheum"},{"key":"4961_CR32","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1194\/jlr.M027367","volume":"53","author":"M Holzer","year":"2012","unstructured":"Holzer M, Wolf P, Curcic S, Birner-Gruenberger R, Weger W, Inzinger M, El-Gamal D, Wadsack C, Heinemann A, Marsche G (2012) Psoriasis alters HDL composition and cholesterol efflux capacity. J Lipid Res 53:1618\u20131624","journal-title":"J Lipid Res"},{"key":"4961_CR33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/jid.2013.359","volume":"134","author":"M Holzer","year":"2014","unstructured":"Holzer M, Wolf P, Inzinger M, Trieb M, Curcic S, Pasterk L, Weger W, Heinemann A, Marsche G (2014) Anti-psoriatic therapy recovers high-density lipoprotein composition and function. J Invest Dermatol 134:635\u2013642","journal-title":"J Invest Dermatol"},{"key":"4961_CR34","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/eurheartj\/ehv339","volume":"36","author":"T Salahuddin","year":"2015","unstructured":"Salahuddin T, Natarajan B, Playford MP, Joshi AA, Teague H, Masmoudi Y, Selwaness M, Chen MY, Bluemke DA, Mehta NN (2015) Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis. Eur Heart J 36:2662\u20132665","journal-title":"Eur Heart J"},{"key":"4961_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11883-015-0554-1","volume":"18","author":"A Bhatt","year":"2016","unstructured":"Bhatt A, Rohatgi A (2016) HDL cholesterol efflux capacity: cardiovascular risk factor and potential therapeutic target. Curr Atheroscler Rep 18:2","journal-title":"Curr Atheroscler Rep"},{"key":"4961_CR36","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/art.39675","volume":"68","author":"MJ Ormseth","year":"2016","unstructured":"Ormseth MJ, Yancey PG, Solus JF, Bridges SL Jr, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, Kon V, Michael Stein C, Investigators T (2016) Effect of drug therapy on net cholesterol efflux capacity of high-density lipoprotein-enriched serum in rheumatoid arthritis. Arthritis Rheum 68:2099\u20132105","journal-title":"Arthritis Rheum"},{"key":"4961_CR37","doi-asserted-by":"crossref","unstructured":"Liao KP, Playford MP, Frits M, Coblyn JS, Iannaccone C, Weinblatt ME, Shadick NS, Mehta NN (2015) The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. J Am Heart Assoc 4","DOI":"10.1161\/JAHA.114.001588"},{"key":"4961_CR38","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, Mikkelsen K, Borghi MO, Favalli EG, Gatti R, Hollan I, Meroni PL, Bernini F (2015) Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheum 67:1155\u20131164","journal-title":"Arthritis Rheum"},{"key":"4961_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.3390\/ijerph7010325","volume":"7","author":"T Faresjo","year":"2010","unstructured":"Faresjo T, Faresjo A (2010) To match or not to match in epidemiological studies--same outcome but less power. Int J Environ Res Public Health 7:325\u2013332","journal-title":"Int J Environ Res Public Health"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-020-04961-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-04961-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T00:24:42Z","timestamp":1611707082000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-020-04961-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["4961"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-04961-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]},"assertion":[{"value":"14 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Research was carried out in compliance with the Helsinki Declaration. The study protocol was approved by the Institutional Review Committee at Hospital Universitario de Canarias and all subjects provided informed written consent (Approval Number 2016_88).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}